Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey
Micafungin was reported to be non-inferior to liposomal amphotericin B (LAmB) in treating patients with candidaemia and invasive candidiasis (IC). The current study aimed to evaluate the economic impact of using micafungin versus LAmB for treatment of candidaemia and IC in Turkey. A decision analyti...
| Published in: | European Journal of Clinical Microbiology and Infectious Diseases |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Springer Verlag
2018
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049144871&doi=10.1007%2fs10096-018-3312-9&partnerID=40&md5=81f64e080624db11c3deb824749b6315 |